| Benign Peripheral Nervous System Neoplasm studied in …STUDIED_INderived61 of 61show fewer |
|---|
| → studied in | NCT00924196active not recruiting Natural History Study of Patients With Neurofibromatosis Type I · condition mapped ONTOLOGY_EXACT · 61 trials mapped (31 active) | — | — | Plexiform Neurofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00314119completed Natural History and Biology of Skin Neurofibromas in Neurofibromatosis Type 1 · condition mapped ONTOLOGY_EXACT · 61 trials mapped (31 active) | — | — | Neurofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01362803Phase 1/Phase 2 · active not recruiting AZD6244 Hydrogen Sulfate for Children With Nervous System Tumors · condition mapped ALIAS · 61 trials mapped (31 active) | — | — | Plexiform Neurofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06175637active not recruiting Observational Study to Evaluate the Effect and Safety of Selumetinib in Pediatric Patients With NF1-PNs · condition mapped ALIAS · 61 trials mapped (31 active) | — | — | Plexiform Neurofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07298083recruiting DoD Award NF230020 Identification of Metabolic Markers and Statistical Prediction of MPNST for Rapid Diagnosis and Assessment of Surgical Margins · condition mapped ALIAS · 61 trials mapped (31 active) | — | — | Neurofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06515860enrolling by invitation Neurofibromatosis Type 1 Tumor Early Detection Study · condition mapped ONTOLOGY_EXACT · 61 trials mapped (31 active) | — | — | Plexiform Neurofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02402244recruiting Project: Every Child for Younger Patients With Cancer · condition mapped ONTOLOGY_EXACT · 61 trials mapped (31 active) | — | — | Ganglioneuroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06360406recruiting Real-World Treatment Study of Koselugo (Selumetinib) · condition mapped ONTOLOGY_EXACT · 61 trials mapped (31 active) | — | — | Plexiform Neurofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02390752Phase 1 · recruiting Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ... · condition mapped ONTOLOGY_EXACT · 61 trials mapped (31 active) | — | — | Plexiform Neurofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06502171Phase 1 · recruiting Study of Cabozantinib With Selumetinib for Plexiform Neurofibromas · condition mapped ONTOLOGY_EXACT · 61 trials mapped (31 active) | — | — | Plexiform Neurofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04590235Phase 1 · active not recruiting A Study of Selumetinib in Chinese Paediatric and Adult Subjects With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas (PN) · condition mapped ALIAS · 61 trials mapped (31 active) | — | — | Plexiform Neurofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06880991recruiting Development of Patient-Reported Outcome Measures Assessing Tumor Visibility and Appearance Concerns in Neurofibromatosis Type 1: A Qualitative Study · condition mapped ONTOLOGY_EXACT · 61 trials mapped (31 active) | — | — | Neurofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03962543Phase 2 · active not recruiting MEK Inhibitor Mirdametinib (PD-0325901) in Patients With Neurofibromatosis Type 1 Associated Plexiform Neurofibromas · condition mapped ONTOLOGY_EXACT · 61 trials mapped (31 active) | — | — | Plexiform Neurofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05891847terminated Non-interventional Study of Patients With PN NF1 Starting Selumetinib in Russia · condition mapped ONTOLOGY_EXACT · 61 trials mapped (31 active) | — | — | Neurofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06104488Phase 1 · active not recruiting A Study of Avutometinib for People With Solid Tumor Cancers · condition mapped ONTOLOGY_EXACT · 61 trials mapped (31 active) | — | — | Plexiform Neurofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06188741Phase 2 · recruiting Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1 · condition mapped ONTOLOGY_EXACT · 61 trials mapped (31 active) | — | — | Plexiform Neurofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07407803Phase 3 · recruiting Evaluation of TQ-B3234 Capsules in Patients With Symptomatic, Non-Surgical Type 1 Neurofibromatosis-Associated Plexiform Neurofibromas · condition mapped ONTOLOGY_EXACT · 61 trials mapped (31 active) | — | — | Plexiform Neurofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03583528active not recruiting DOTATOC PET/CT for Imaging NET Patients · condition mapped ONTOLOGY_EXACT · 61 trials mapped (31 active) | — | — | Ganglioneuroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07102394Phase 1 · recruiting Feasibility and Tolerability of IMLYGIC for the Treatment of Cutaneous Neurofibromas in Adults With NF1 · condition mapped ALIAS · 61 trials mapped (31 active) | — | — | Skin Neurofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03363217Phase 2 · active not recruiting Trametinib for Pediatric Neuro-oncology Patients With Refractory Tumor and Activation of the MAPK/ERK Pathway. · condition mapped ONTOLOGY_EXACT · 61 trials mapped (31 active) | — | — | Plexiform Neurofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06300502Phase 1 · enrolling by invitation Assessing the Efficacy of Repeat, Monthly Treatments of Deoxycholate for NF1 Associated Cutaneous Neurofibromas (cNFs) · condition mapped ALIAS · 61 trials mapped (31 active) | — | — | Neurofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06159166Phase 1/Phase 2 · recruiting Mirdametinib Monotherapy in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF). · condition mapped ALIAS · 61 trials mapped (31 active) | — | — | Skin Neurofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04040088early Phase 1 · active not recruiting An Investigational Scan (68Ga-DOTATATE PET/CT) in Diagnosing Pediatric Metastatic Neuroendocrine Tumors · condition mapped ONTOLOGY_EXACT · 61 trials mapped (31 active) | — | — | Ganglioneuroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04924608Phase 3 · active not recruiting Efficacy and Safety of Selumetinib in Adults With NF1 Who Have Symptomatic, Inoperable Plexiform Neurofibromas · condition mapped ONTOLOGY_EXACT · 61 trials mapped (31 active) | — | — | Plexiform Neurofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05005845Phase 2 · completed NFX-179 Topical Gel Treatment for Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF) · condition mapped ALIAS · 61 trials mapped (31 active) | — | — | Skin Neurofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06322342Phase 2 · completed Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent · condition mapped ONTOLOGY_EXACT · 61 trials mapped (31 active) | — | — | Neurofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06961565Phase 1 · recruiting PAS-004 in Adults Who Have Neurofibromatosis Type 1 With Plexiform Neurofibromas · condition mapped ALIAS · 61 trials mapped (31 active) | — | — | Plexiform Neurofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05581511active not recruiting Natural History Study of Cutaneous Neurofibromas in People With NF1 · condition mapped ALIAS · 61 trials mapped (31 active) | — | — | Skin Neurofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05192980NA · recruiting SIOPEN BIOPORTAL, An International Registry Linked to a Virtual Biobank for Patients With Peripheral Neuroblastic Tumours · condition mapped ONTOLOGY_EXACT · 61 trials mapped (31 active) | — | — | Ganglioneuroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07024394Phase 1/Phase 2 · not yet recruiting Follow-up Study to Evaluate the Safety and Efficacy of FCN-159 in Pediatric Participants With Neurofibromatosis Type 1 · condition mapped ONTOLOGY_EXACT · 61 trials mapped (31 active) | — | — | Plexiform Neurofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03231306Phase 2 · completed Phase II Study of Binimetinib in Children and Adults With NF1 Plexiform Neurofibromas · condition mapped ONTOLOGY_EXACT · 61 trials mapped (31 active) | — | — | Plexiform Neurofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05913037Phase 3 · active not recruiting FCN-159 in Adult Patients With Symptomatic, Inoperable Neurofibromatosis Type 1-Related Plexiform Neurofibromas · condition mapped ONTOLOGY_EXACT · 61 trials mapped (31 active) | — | — | Plexiform Neurofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04730583Phase 1 · completed Tolerability of Device Based Therapies for Neurofibromatosis Type 1 Cutaneous Neurofibromas · condition mapped ALIAS · 61 trials mapped (31 active) | — | — | Skin Neurofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04954001Phase 1/Phase 2 · active not recruiting Study to Evaluate the Safety, Tolerability, PK Characteristics and Anti-tumor Activity of FCN-159 in Adult and Pediatric Participants With Neurofibromatosis Type 1 · condition mapped ONTOLOGY_EXACT · 61 trials mapped (31 active) | — | — | Plexiform Neurofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03531814NA · completed Medication Adherence in Children, Adolescents and Adults With Neurofibromatosis Type 1(NF1) on Clinical Treatment Trials · condition mapped ONTOLOGY_EXACT · 61 trials mapped (31 active) | — | — | Plexiform Neurofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06296732recruiting Abdominal Neuroblastoma Laparoscopic Surgery Risk Factors Stratification · condition mapped ONTOLOGY_EXACT · 61 trials mapped (31 active) | — | — | Ganglioneuroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05438290Phase 1 · completed DPCP to Treat Cutaneous Neurofibromas Associated With NF1 · condition mapped ALIAS · 61 trials mapped (31 active) | — | — | Skin Neurofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06379230unknown A Retrospective Study on Epidemiological Characteristics of Chinese NF1 Patients in Real World (PROMISE) · condition mapped ONTOLOGY_EXACT · 61 trials mapped (31 active) | — | — | Plexiform Neurofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03741101Phase 2 · unknown Treatment of NF1-related Plexiform Neurofibroma With Trametinib · condition mapped ONTOLOGY_EXACT · 61 trials mapped (31 active) | — | — | Plexiform Neurofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03326388Phase 1/Phase 2 · completed Intermittent Dosing Of Selumetinib In Childhood NF1 Associated Tumours · condition mapped ONTOLOGY_EXACT · 61 trials mapped (31 active) | — | — | Plexiform Neurofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05199376NA · recruiting Evaluation of Percutaneous Cryotherapy in the Treatment of Plexiform Neurofibromas and Unresectable Neurofibromas in Neurofibromatosis Type 1 · condition mapped ONTOLOGY_EXACT · 61 trials mapped (31 active) | — | — | Neurofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02839720Phase 2 · completed Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Cutaneous Neurofibroma · condition mapped ALIAS · 61 trials mapped (31 active) | — | — | Skin Neurofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04435665Phase 2 · completed NFX-179 Topical Gel Treatment in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF) · condition mapped ALIAS · 61 trials mapped (31 active) | — | — | Skin Neurofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01800032completed PET/MRI in CNS and Extra-CNS Tumors of Patients With Neurofibromatosis-1 (NF1) · condition mapped ONTOLOGY_EXACT · 61 trials mapped (31 active) | — | — | Plexiform Neurofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03820778NA · active not recruiting Whole Body MRI to Identify Atypical Neurofibromas in Patients With NF1 · condition mapped ONTOLOGY_EXACT · 61 trials mapped (31 active) | — | — | Neurofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03688568Phase 2 · withdrawn Study of Imatinib in Children With Neurofibromatosis and Airway Tumors · condition mapped ONTOLOGY_EXACT · 61 trials mapped (31 active) | — | — | Plexiform Neurofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03027401withdrawn Clinical Sequencing of Cancer and Tissue Repository: OncoGenomics · condition mapped ONTOLOGY_EXACT · 61 trials mapped (31 active) | — | — | Plexiform Neurofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01347307NA · completed Stereotactic Body Radiotherapy for Spine Tumors · condition mapped ONTOLOGY_EXACT · 61 trials mapped (31 active) | — | — | Neurofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00727233Phase 1 · completed Sorafenib to Treat Children and Young Adults With Neurofibromatosis Type 1 and Inoperable Plexiform Neurofibromas · condition mapped ONTOLOGY_EXACT · 61 trials mapped (31 active) | — | — | Plexiform Neurofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00076102Phase 2 · completed Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas · condition mapped ONTOLOGY_EXACT · 61 trials mapped (31 active) | — | — | Plexiform Neurofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00021541Phase 2 · completed R115777 to Treat Children With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas · condition mapped ONTOLOGY_EXACT · 61 trials mapped (31 active) | — | — | Plexiform Neurofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00396019Phase 2 · completed Study of PEG-Intron for Plexiform Neurofibromas · condition mapped ONTOLOGY_EXACT · 61 trials mapped (31 active) | — | — | Plexiform Neurofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03090971Phase 2 · completed Use of Topical Liquid Diclofenac Following Laser Microporation of Cutaneous Neurofibromas in Patients With NF1 · condition mapped ALIAS · 61 trials mapped (31 active) | — | — | Skin Neurofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00326872Phase 2 · terminated AZD2171 in Treating Patients With Neurofibromatosis Type 1 and Plexiform Neurofibroma and/or Neurofibroma Near the Spine · condition mapped ONTOLOGY_EXACT · 61 trials mapped (31 active) | — | — | Plexiform Neurofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01140360Phase 1/Phase 2 · completed Pilot Study of Gleevec/Imatinib Mesylate (STI-571, NSC 716051) in Neurofibromatosis (NF1) Patient With Plexiform Neurofibromas · condition mapped ALIAS · 61 trials mapped (31 active) | — | — | Neurofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01275586early Phase 1 · completed Study of Tasigna®/Nilotinib (AMN107) in Neurofibromatosis (NF1) Patients With Plexiform Neurofibromas · condition mapped ALIAS · 61 trials mapped (31 active) | — | — | Neurofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01567787NA · withdrawn Proton Radiation Therapy for Spinal Tumors · condition mapped ONTOLOGY_EXACT · 61 trials mapped (31 active) | — | — | Neurofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01999270Phase 1 · completed Evaluation of FDOPA-PET/MRI in Pediatric Patients With CNS Tumors · condition mapped ONTOLOGY_EXACT · 61 trials mapped (31 active) | — | — | Ganglioneuroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00716469Phase 1 · terminated Phase I Clinical Study of the Safety of Photodynamic Therapy (PDT) Using LS11 in Children With Plexiform Neurofibromas · condition mapped ONTOLOGY_EXACT · 61 trials mapped (31 active) | — | — | Neurofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01412892Phase 2 · completed Use of RAD001 as Monotherapy in the Treatment of Neurofibromatosis 1 Related Internal Plexiform Neurofibromas · condition mapped ONTOLOGY_EXACT · 61 trials mapped (31 active) | — | — | Plexiform Neurofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01031901Phase 1 · completed Topical Rapamycin Therapy to Alleviate Cutaneous Manifestations of Tuberous Sclerosis Complex (TSC) and Neurofibromatosis I (NF1) · condition mapped ONTOLOGY_EXACT · 61 trials mapped (31 active) | — | — | Neurofibroma | 1 | Observed | clinicaltrials | graph → |